Vascular brachytherapy revisited for in-stent restenosis in the drug-eluting stent era: Current status and future perspective

Chinese Medical Journal

Volumn 122, Issue 18, 2009, Pages 2174-2179

  Li, Xiong Jie ^a   Rha, Seung Woon ^b   Wani, Sunil P ^b   Wang, Lin ^b   Poddar, Kanhaiya L ^b   Oh, Dong Joo ^b  

^a YANBIAN UNIVERSITY   (China)

^b Korea University College of Medicine   (South Korea)

Author keywords

Brachytherapy; Drug eluting stent; Percutaneous coronary intervention; Restenosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; INDIUM 192; PHOSPHORUS 32; PLACEBO; RADIOISOTOPE; RHENIUM 188; STRONTIUM 90; UNCLASSIFIED DRUG; XENON 133; YTTRIUM;

ANGIOPLASTY; BETA RADIATION; BRACHYTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY ANEURYSM; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DOSIMETRY; DRUG ELUTING STENT; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; GAMMA RADIATION; HUMAN; IN-STENT RESTENOSIS; PATIENT SAFETY; PERIPHERAL VASCULAR DISEASE; RADIATION ENERGY; RADIATION RESPONSE; RADIOACTIVITY; RECURRENT DISEASE; RETREATMENT; REVIEW; THROMBOSIS; TISSUE REGENERATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASCULAR PATENCY; VEIN GRAFT DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; IRIDIUM; RHENIUM; XENON ISOTOPES;

EID: 70350588920     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.18.019     Document Type: Review

References (37)

1. Mintz GS, Weissman NJ, Fitzgerald PJ. Intravascular ultrasound assessment of the mechanisms and results of brachytherapy. Circulation 2001; 104: 1320-1325. (Pubitemid 32848124)
2. Maeder MT, Pfisterer ME, Buser PT, Roser HW, Roth J, Weilenmann D, et al. Long-term outcomes after intracoronary beta-irradiation for in-stent restenosis in bare-metal stents. J Invasive Cardiol 2008; 20: 179-184.
3. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006; 295: 1253-1263.
4. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006; 295: 1264-1273.
5. Rha SW, Kuchulakanti PK, Pakala R, Pichard AD, Satler LF, Kent KM, et al. Real-world clinical practice of intracoronary radiation therapy as compared to investigational trials. Catheter Cardiovasc Interv 2005; 64: 61-66. (Pubitemid 40069892)
6. Condado JA, Waksman R, Gurdiel O, Espinosa R, Gonzalez J, Burger B, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96: 727-732. (Pubitemid 27329602)
7. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336: 1697-1703. (Pubitemid 27251783)
8. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000; 101: 2165-2171. (Pubitemid 30253045)
9. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344: 250-256. (Pubitemid 32108529)
10. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002; 106: 1090-1096. (Pubitemid 34970849)
11. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002; 359: 551-557. (Pubitemid 34178435)
12. Waksman R, Cheneau E, Ajani AE, White RL, Pinnow E, Torguson R, et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 2003; 107: 1744-1749. (Pubitemid 36418354)
13. Ahmed JM. Serial intravascular ultrasound assessment of the efficacy of intracoronary gamma radiation for preventing recurrent in-stent restenosis. Minerva Cardioangiol 2002; 50: 507-515.
14. Verin V, Popowski Y, de Bruyne B, Baumgart D, Sauerwein W, Lins M, et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med 2001; 344: 243-249. (Pubitemid 32108528)
15. Waksman R, Ajani AE, White RL, Chan RC, Satler LF, Kent KM, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 2002; 346: 1194-1199. (Pubitemid 34984580)
16. Rha SW, Kuchulakanti P, Ajani AE, Cheneau E, Pinnow EE, Canos DA, et al. Three-year follow-up after intravascular gamma-radiation for in-stent restenosis in saphenous vein grafts. Catheter Cardiovasc Interv 2005; 65: 257-262. (Pubitemid 40791522)
17. Ajani AE, Waksman R, Cheneau E, Cha DH, Leborgne L, Sharma AK, et al. Comparison of intracoronary gamma radiation for in-stent restenosis in saphenous vein grafts versus native coronary arteries. Am J Cardiol 2003; 91: 22-26. (Pubitemid 36050766)
18. Costantini CO, Lansky AJ, Mintz GS, Shirai K, Dangas G, Mehran R, et al. Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions. J Am Coll Cardiol 2003; 41: 1725-1731. (Pubitemid 36584243)
19. Sharma AK, Ajani AE, Garg N, Cheneau E, Wolfram R, Chan R, et al. Usefulness of gamma intracoronary radiation for totally occluded in-stent restenotic coronary narrowing. Am J Cardiol 2003; 91: 595-597. (Pubitemid 36263264)
20. Jain D, Geist V, Lorenzen HP, Hartmann F, Wegscheider K, Bonan R, et al. Intracoronary beta-brachytherapy in chronic total occlusions: a subgroup analysis from the RENO registry. Catheter Cardiovasc Interv 2003; 58: 322-329. (Pubitemid 36259219)
21. Gruberg L, Waksman R, Ajani AE, Kim HS, White RL, Pinnow EE, et al. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus. J Am Coll Cardiol 2002; 39: 1930-1936. (Pubitemid 34628273)
22. Condado JA, Waksman R, Saucedo JF, Bhargava B, Lansky AJ, Calderas C, et al. Five-year clinical and angiographic follow-up after intracoronary iridium-192 radiation therapy. Cardiovasc Radiat Med 2002; 3: 74-81. (Pubitemid 36434168)
23. Verin V, Urban P, Popowski Y, Schwager M, Nouet P, Dorsaz PA, et al. Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study. Circulation 1997; 95: 1138-1144.
24. King SB 3rd, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R, et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998; 97: 2025-2030.
25. Raizner AE, Oesterle SN, Waksman R, Serruys PW, Colombo A, Lim YL, et al. Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 2000; 102: 951-958. (Pubitemid 30656002)
26. Hoher M, Wohrle J, Wohlfrom M, Kamenz J, Nusser T, Grebe OC, et al. Intracoronary beta-irradiation with a rhenium-188-filled balloon catheter: a randomized trial in patients with de novo and restenotic lesions. Circulation 2003; 107: 3022-3027.
27. Stone GW, Mehran R, Midei M, Waksman R, Schaer GL, Negoita M, et al. Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. Am J Cardiol 2003; 92: 312-314.
28. Lekston A, Chudek J, Gasior M, Wilczek K, Wiecek A, Kokot F, et al. Angiographic and intravascular ultrasound assessment of immediate and 9-month efficacy of percutaneous transluminal renal artery balloon angioplasty with subsequent brachytherapy in patients with renovascular hypertension. Kidney Blood Press Res 2008; 31: 291-298.
29. Kuiper KK, Salem M, Rotevatn S, Mills J , Nordrehaug JE. Implementing a best-treatment strategy with intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence. Cardiovasc Revasc Med 2007; 8: 9-14. (Pubitemid 46216176)
30. Torguson R, Sabate M, Deible R, Smith K, Chu WW, Kent KM, et al. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. Am J Cardiol 2006; 98: 1340-1344. (Pubitemid 44666639)
31. Cheneau E, Waksman R, Yazdi H, Chan R, Fourdnadjiev J, Berzingi C, et al. How to fix the edge effect of catheter-based radiation therapy in stented arteries. Circulation 2002; 106: 2271-2277. (Pubitemid 35222224)
32. Maehara A, Mintz GS, Weissman NJ, Bui AB, Castagna MT, Ajani AE, et al. Late thrombosis after gamma-brachytherapy. Catheter Cardiovasc Interv 2003; 58: 455-458.
33. Waksman R, Ajani AE, Pinnow E, Cheneau E, Leborgne L, Dieble R, et al. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation 2002; 106: 776-778.
34. Oliver LN, Buttner PG, Hobson H, Golledge J. A meta-analysis of randomised controlled trials assessing drug-eluting stents and vascular brachytherapy in the treatment of coronary artery in-stent restenosis. Int J Cardiol 2008; 126: 216-223. (Pubitemid 351611666)
35. Wohrle J, Nusser T, Krause BJ, Kochs M, Habig T, Mottaghy FM, et al. Patients with in-stent restenoses: comparison of intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter with the polymer-based paclitaxel-eluting taxus-express stent. Nuklearmedizin 2007; 46: 185-191. (Pubitemid 47612283)
36. Park SW, Lee SW, Koo BK, Park DW, Kim YH, Lee CW, et al. Treatment of diffuse in-stent restenosis with drug-eluting stents vs intracoronary beta-radiation therapy: INDEED Study. Int J Cardiol 2008; 131: 70-77.
37. Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, et al. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J 2008; 29: 1625-1634. (Pubitemid 351958446)